http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106632337-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-34 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-34 |
| filingDate | 2016-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106632337-B |
| titleOfInvention | It ends for this crystal form, pharmaceutical composition, preparation method and purposes of Larry |
| abstract | The present invention relates to Chinese mugworts for this crystal form, pharmaceutical composition, preparation method and purposes of Larry, belongs to medical compounds crystal technology field.The present invention specifically provides a kind of crystal form R, has X-ray powder diffraction collection substantially as shown in Figure 1, Figure 2 or shown in Fig. 9 using Cu-K α radiation.The crystal form R preparation method is easy, and crystal form is easily controllable, and production efficiency significantly improves, industrialized production preferably.The crystal form has improved hygroscopicity, chemical stability and preparation adaptability, and has good drug effect and safety. |
| priorityDate | 2016-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 98.